Administrative Core Leadership Team
Interim Associate Provost and Associate Vice President for Research,
TSU Professor of Pharmacology, COPHS
Dr. Olaleye is an expert in drug discovery with the characterization of multiple promising drug leads and novel assay development, with focus on infectious diseases. She has rich experience in education and training in biomedical research.
Dr. Olaleye is responsible to provide institutional support from the university administration level and to ensure CBMHR as top priority in the university’s research strategic plan. She is also responsible to facilitate smooth operations of CBMHR activities related to those offices under her supervision, such as the Office of Research and Office of Grants and Contracts. She is further responsible to communicate with NIMHD, promote inter-college collaborations within TSU, as well as facilitate inter-university or inter-institution collaborations and partnerships with other RCMI institutions, TMC institutions and beyond, and to disseminate extramural funding opportunities to CBMHR investigators.
TSU Professor of Pharmaceutics, COPHS,
Program Director, PhD Program in Pharmaceutical Sciences
Dr. Xie is a Professor of Pharmaceutics in the COPHS, with 16 years of experience in industry and academia in novel nano-drug delivery, and successfully led the previous RCMI program Pharmacology Core that provided support to > 20 external and internal users and > 40 projects. Dr. Xie is co-Director of Center of Comprehensive PKPD & Formulation (CCPF) supported by CPRIT, and PI of several previous NIH and foundation funded research grants, many of which were awarded for the first time to TSU. She is an inventor on 3 patents related to novel drug formulation and PK study and has many collaborators across Texas. She brings in extensive grant management experience as well as rich research expertise in novel drug delivery, nanotechnology, and preclinical drug development.
Dr. Xie is responsible for overall operation of the program. Specifically, she oversees financial and administrative management of each core of the activities such as personnel hiring, budget adjustment, procurement and regulatory compliance. She is also responsible for correspondences and meetings with the Advisory Committee (AC) to guide CBMHR and responsible for the annual and bi-annual progress report of the CMBHR center program. She is further responsible for scientific merit of CBMHR through the proposed multiple activities including career development, seminars, symposiums, and mentoring.
TSU Professor of Pharmaceutics and
Interim Associate Dean of Research, COPHS
Dr. Liang has more than 30 years of industrial and academic expertise in pre-clinical and Phase I PK and drug development studies. He has worked on Phase I PK studies from protocol design (clinical study monitoring; bioanalysis; and statistical PK data interpretation) to FDA submissions for over 35 generic drug product approvals. He is co-inventor of 5 U.S. patents in dosage formulation development. He is the Director of CCPF.
Dr. Liang has been the PD for TSU RCMI program since 2008, and now continue to serve as the Director of the ADC and responsible for day to day operations of the CBMHR including ordering supplies, tracking activities, and organizing regular meetings and communications within CBMHR. He will also be responsible to assist the RIC core directors in developing and implementing novel scientific research resources for TSU investigators and collaborators. He will be in charge of evaluation and monitoring of the overall progress with support from internal and external evaluators.
Dr. Jenkins is an educational developer with 13 years experience in designing, implementing, and leading professional development initiatives for faculty, students and administrators in higher education institutions. In her current position as the founding Executive Director of the TEAM Center, she oversees the development and execution of the College’s faculty professional development and student academic support programs. Her scholarship in culturally responsive pedagogy, faculty development, and adult learning largely informs her professional development practice.
Dr. Jenkins will be responsible for coordinating the mentorship program and will assist PIs/PD in career development activities including the faculty development workshop, mentor-mentee pairing, and development process.